Ultragenyx Pharmaceutical Inc.RARENASDAQ
Loading
Operating Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+3.8%
5Y CAGR+13.1%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+3.8%/yr
vs +23.6%/yr prior
5Y CAGR
+13.1%/yr
Recent deceleration
Acceleration
-19.8pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.8x
Solid growth
Streak
2 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $1.10B | +7.8% |
| 2024 | $1.02B | +6.4% |
| 2023 | $958.25M | -2.6% |
| 2022 | $983.93M | +37.2% |
| 2021 | $717.13M | +20.5% |
| 2020 | $595.02M | +14.7% |
| 2019 | $518.88M | +23.0% |
| 2018 | $421.72M | +27.2% |
| 2017 | $331.55M | +33.6% |
| 2016 | $248.14M | - |